Drug Profile
Milfasartan
Alternative Names: LRB 081Latest Information Update: 21 Oct 1998
Price :
$50
*
At a glance
- Originator Istituto Lusofarmaco
- Class Antihypertensives
- Mechanism of Action Angiotensin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 21 Oct 1998 Discontinued-II for Hypertension in Czech Republic (Unknown route)
- 21 Oct 1998 Discontinued-II for Hypertension in Italy (Unknown route)
- 21 Oct 1998 Discontinued-II for Hypertension in United Kingdom (Unknown route)